Showing results (1461-1470 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|February 24, 2026
Cyclooxygenase-2 Inhibition and Anti-Platelet Aggregation Activity of Astaxanthin-Hydrogel in Comparison to Celecoxib Against Rheumatoid Arthritis in Wistar Rat ModelAnzeela Ghaffar, Sumaira Sharif, Quindeel Naveed, et al.Biopharmaceutics & Drug Disposition|July 1, 1991
A method for calculating the mean residence times of catenary metabolitesH Y ChengBiopharmaceutics & Drug Disposition|March 1, 1996
Disposition decomposition analysis for pharmacodynamic modeling of the link compartmentH Cheng, W J JuskoBiopharmaceutics & Drug Disposition|December 30, 2016
Prioritizing pharmacokinetic drug interaction precipitants in natural products: application to OATP inhibitors in grapefruit juiceEmily J Johnson, Christina S Won, Kathleen Köck, et al.Biopharmaceutics & Drug Disposition|December 16, 2016
Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictionsJean-Marie Nicolas, François Bouzom, Chanteux Hugues, et al.Biopharmaceutics & Drug Disposition|March 13, 2014
Disposition of d-penicillamine, a promising drug for preventing alcohol-relapse. Influence of dose, chronic alcohol consumption and age: studies in ratsAlejandro Orrico, Lucía Martí-Prats, M José Cano-Cebrián, et al.Biopharmaceutics & Drug Disposition|May 23, 2008
Enzymatic stability of 2'-ethylcarbonate-linked paclitaxel in serum and conversion to paclitaxel by rabbit liver carboxylesterase for use in prodrug/enzyme therapyTadatoshi Tanino, Akihiro Nawa, Yasuyoshi Miki, et al.Biopharmaceutics & Drug Disposition|March 1, 1988
Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjectsP V Parab, W A Ritschel, D E Coyle, et al.Biopharmaceutics & Drug Disposition|March 5, 2014
Pharmacokinetics of tolbutamide and its metabolite 4-hydroxy tolbutamide in poloxamer 407-induced hyperlipidemic ratsMi Ran Choi, Mi Hye Kwon, Yong Yeon Cho, et al.Biopharmaceutics & Drug Disposition|October 27, 2018
CYP2J2 is the major enzyme in human liver microsomes responsible for hydroxylation of SYL-927, a novel and selective sphingosine 1-phosphate receptor 1 (S1P1 ) agonistShu Yang, Jinping Hu, Yan Li, et al.Pageof 214